SCHEMBL25976376

SCHEMBL25976376

Cc1ccc(-c2ccccc2)cc1-c1cc(C(C)C)c(C)c[n+]1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
APAF1 O14727 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
XBP1 P17861 1/20 0.34
PTBP1 P26599 1/20 0.34
RAB9A P51151 1/20 0.34
GALK1 P51570 1/20 0.34
BLM P54132 1/20 0.34
SMAD3 P84022 1/20 0.34
ATM Q13315 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25977626 0.89 HTT (0.34) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25976745 0.89 AR (0.35) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL25446154 0.86 ESR2 (0.36) HTTSMN1; SMN2KMT2ALMNANPC1
SCHEMBL25976556 0.85 HTT (0.36) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25452197 0.84 HTT (0.37) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25517571 0.82 LMNA (0.32) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25452230 0.81 LMNA (0.40) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25976411 0.80 CYP1A2 (0.33) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25976558 0.80 SLC6A9 (0.38) HTTSMN1; SMN2KMT2ALMNAMEN1
SCHEMBL25446151 0.79 ESR2 (0.35) HTTSMN1; SMN2KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 HTT 3085/4885SMN1; SMN2 3169/4885KMT2A 3458/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 HTT 3085/4885SMN1; SMN2 3169/4885KMT2A 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.